Episurf Medical Hires Stephen Caswell to Lead OUS Global Sales

Episurf Medical (NASDAQ: EPIS B) today announced the hiring of Stephen caswell as Head of Sales, OUS. In this role, Stephen will define and execute the strategic sales strategy for Episurf markets outside of the we and Canada, working closely with the direct sales force and indirect sales partners of the company to accelerate growth. Ensuring that more patients in this underserved segment can benefit from a personalized treatment platform to help reduce pain and maximize function. Stephen will focus on business acceleration, market development and brand positioning in international markets.

Stephen has spent the past 7 years with Stryker’s Joint Replacement Division in a variety of roles spanning Mako Robotics direct sales, sales management and marketing with a focus on the public and private sectors, and most recently held the position of position of commercial director of strategic capabilities. In his role at Mako Robotics, Stephen has focused on commercializing patient-specific 3D planning tools for knee replacement procedures.

Prior to Stryker, Stephen practiced as a registered physiotherapist for 11 years, working both in the UK public and private sectors. In this segment, he built a business which was then sold. Stephen also holds a BSc First Class Hons in Physiotherapy, an MSc in Sports Medicine and an Executive MBA.

“I am incredibly passionate about this segment of underserved patients” explains Stephen; “With the combination of detailed 3D planning and damage reporting, patient specific implants and 3D printed patient specific instrumentation, we have a fantastic opportunity to expand the use of this platform. -treatment form to provide better results for this group of highly functional patients ”. Stephen goes on to explain “When this is combined with the robust clinical data the company has diligently captured, we are well positioned to experience significant growth in multiple markets.”

“I am delighted to have Stephen on board for this incredibly important mission. In addition to his solid background in the industry, Stephen is very passionate about helping patients, as evidenced by his experience in physiotherapy. Episurf is moving from research and development to commercialization, and Stephen will play an important role in ensuring that we take the next steps “, says Pål Ryfors, CEO Episurf Medical.

For more information please contact:

Pål Ryfors, CEO, Episurf Medical
Phone: +46 (0) 709 62 36 69
Email: pal.ryfors@episurf.com

On Episurf Medical

Episurf Medical strives to bring people with painful joint injuries a more active and healthier life through the availability of minimally invasive and individualized treatment alternatives. Episurf Medical Episealer® individualized implants and Epiguide® surgical drill guides are developed for the treatment of localized cartilage damage in the joints. Episurf Medical The μiFidelity® system allows implants to be cost-effectively matched to each individual’s unique injury for optimal fit and minimal intervention. Episurf Medical the head office is at Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, visit the company website: www.episurf.com.

This information is information that Episurf Medical AB is required to make public in accordance with the EU Market Abuse Regulation. The information was submitted for publication, through the contact person indicated above, at 08:00 CET on December 3, 2021.




(c) Decision 2021. All rights reserved., source Press Releases – English

Source link

About Leona A. Yow

Check Also

Medical Supplies Market Worth $163.5 Billion by 2027 – Exclusive Report by MarketsandMarkets™

/EIN News/ — Chicago, Aug. 05, 2022 (GLOBE NEWSWIRE) — The medical supplies market is …